Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA324609
Max Phase: Preclinical
Molecular Formula: C7H14NO8P
Molecular Weight: 271.16
Molecule Type: Small molecule
Associated Items:
ID: ALA324609
Max Phase: Preclinical
Molecular Formula: C7H14NO8P
Molecular Weight: 271.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)O[C@H](COP(=O)(O)O)[C@H](C(=O)NO)O1
Standard InChI: InChI=1S/C7H14NO8P/c1-7(2)15-4(3-14-17(11,12)13)5(16-7)6(9)8-10/h4-5,10H,3H2,1-2H3,(H,8,9)(H2,11,12,13)/t4-,5-/m1/s1
Standard InChI Key: DVFAQEVWJBLFDS-RFZPGFLSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 271.16 | Molecular Weight (Monoisotopic): 271.0457 | AlogP: -0.88 | #Rotatable Bonds: 4 |
Polar Surface Area: 134.55 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.20 | CX Basic pKa: | CX LogP: -1.38 | CX LogD: -4.96 |
Aromatic Rings: 0 | Heavy Atoms: 17 | QED Weighted: 0.29 | Np Likeness Score: 1.18 |
1. Dardonville C, Rinaldi E, Barrett MP, Brun R, Gilbert IH, Hanau S.. (2004) Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues., 47 (13): [PMID:15189039] [10.1021/jm031066i] |
2. Ruda GF, Campbell G, Alibu VP, Barrett MP, Brenk R, Gilbert IH.. (2010) Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase., 18 (14): [PMID:20598892] [10.1016/j.bmc.2010.05.077] |
3. Ruda GF, Wong PE, Alibu VP, Norval S, Read KD, Barrett MP, Gilbert IH.. (2010) Aryl phosphoramidates of 5-phospho erythronohydroxamic acid, a new class of potent trypanocidal compounds., 53 (16): [PMID:20666371] [10.1021/jm1004754] |
4. Yep A, Sorenson RJ, Wilson MR, Showalter HD, Larsen SD, Keller PR, Woodard RW.. (2011) Enediol mimics as inhibitors of the D-arabinose 5-phosphate isomerase (KdsD) from Francisella tularensis., 21 (9): [PMID:21236668] [10.1016/j.bmcl.2010.12.066] |
Source(1):